antifungal/seizures

This invention relates to N-mono(alkoxymethyl)phenobarbitals, to a process therefor, to therapeutic compositions containing same and to their use as agents for treating convulsions and seizures in warm-blooded animals. Recently a series of N,N'-bis(alkoxymethyl)phenobarbitals has been prepared and

BACKGROUND OF THE INVENTION The present invention relates to the field of medical devices to treat neurological disorders of the brain. Complex dynamic systems that are open to energy/mass and/or information exchanges with their environment typically display emergent properties of self organization

TECHNICAL FIELD The present invention relates to electroconvulsive therapy (ECT) and more particularly an improved electroconvulsive therapy (ECT) treatment including methodology for simultaneously and accurately predicting seizure adequacy during treatment. RELATED ART Electroconvulsive therapy

TECHNICAL FIELD Methods of treating developmental disorders and/or seizure disorders with etifoxine are provided. BACKGROUND Treatments for developmental disorders such as Autistic Spectrum Disorder, Dravet syndrome, Rett syndrome, Angelman syndrome, Fragile X syndrome, and Fragile X-associated

FIELD OF THE INVENTION The present invention relates to bridged dianilino compounds and pharmaceutical compositions and method of use thereof for the prevention and treatment of epilepsies, seizures, and other electroconvulsive disorders. Specifically, this invention relates to the use of

BACKGROUND Temporal lobe epilepsy is the most common focal epilepsy in adolescents and adults, and the most frequent indication for epilepsy surgery. Mesial temporal lobe epilepsy (MTLE) often originates from the hippocampus, which is implicated in declarative memory function. A clinical trial in

FIELD OF THE INVENTION The invention relates to prediction and control methods and systems to treat neurological disorders. In particular, the invention relates to epileptic seizure prediction and treatment methods and systems. BACKGROUND OF THE INVENTION Epilepsy is a multifaceted neurological

BACKGROUND OF THE INVENTION This invention was made with Government support under contract AI47822 and GM37734. The government has certain rights in this invention. A seizure is a paroxysmal event due to abnormal, excessive, hypersynchronous discharges from an aggregate of central nervous system

BACKGROUND OF THE INVENTION A seizure is a paroxysmal event due to abnormal, excessive, hypersynchronous discharges from an aggregate of central nervous system (CNS) neurons, while epilepsy is a condition in which a person has recurrent seizures due to a chronic, underlying process. Experimental and

TECHNICAL FIELD Methods of treating seizure disorders are provided. BACKGROUND Seizure disorders typically involve abnormal nerve cell activity in the brain, causing seizures which may be manifested by periods of unusual behavior, sensations, diminished consciousness and sometimes loss of

BACKGROUND OF THE INVENTION The present invention is generally in the field of nutritional and therapeutic compositions for the modulation of ketone levels in humans and other mammals. There are a number of conditions in human and animals in which it is desirable to increase the levels of ketone

FIELD OF THE INVENTION The present invention relates to bupropion hydrobromide and bupropion hydrobromide formulations as, well as their use for the treatment of conditions (e.g. major depressive disorder, bipolar depression mood disorder, other mood disorder, anxiety disorders, generalized anxiety

1. FIELD OF THE INVENTION The present invention relates to Piperazine Compounds, compositions comprising a Piperazine Compound and methods for treating or preventing a condition such as pain, urinary incontinence (UI), an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy,

REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY The content of the electronically submitted Sequence Listing (Name: sequence_listing_ascii.txt; Size: 766 bytes; and Date of Creation: Mar. 19, 2012) filed herewith is incorporated herein by reference in its entirety. 1. FIELD OF THE

1. FIELD OF THE INVENTION The present invention relates to Piperazine Compounds; compositions comprising a Piperazine Compound; and methods for preventing or treating pain, urinary incontinence (UI), an ulcer, inflammatory-bowel disease (IBD), irritable-bowel syndrome (IBS), an addictive disorder,